An update on tirzepatide for the management of type 2 diabetes: a focus on the phase 3 clinical development program.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- An update on tirzepatide for the management of type 2 diabetes: a focus on the phase 3 clinical development program.
- Published In:
- Expert review of endocrinology & metabolism, 18(2), 111-130 (2023)
- Authors:
- Frías, Juan Pablo
- Database ID:
- RPEP-06886
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06886APA
Frías, Juan Pablo. (2023). An update on tirzepatide for the management of type 2 diabetes: a focus on the phase 3 clinical development program.. Expert review of endocrinology & metabolism, 18(2), 111-130. https://doi.org/10.1080/17446651.2023.2184796
MLA
Frías, Juan Pablo. "An update on tirzepatide for the management of type 2 diabetes: a focus on the phase 3 clinical development program.." Expert review of endocrinology & metabolism, 2023. https://doi.org/10.1080/17446651.2023.2184796
RethinkPeptides
RethinkPeptides Research Database. "An update on tirzepatide for the management of type 2 diabet..." RPEP-06886. Retrieved from https://rethinkpeptides.com/research/frias-2023-an-update-on-tirzepatide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.